Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.

Por Eric C Sorenson, Raya Khanin, Zubin M Bamboat, Michael J Cavnar, Teresa S Kim, Eran Sadot, Shan Zeng, Jonathan B Greer, Adrian M Seifert, Noah A Cohen, Noah A Cohen, Megan H Crawley, Benjamin L Green, David S Klimstra, Ronald P DeMatteo
Publicado em 2017-01-01